Ibnsina Pharma Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,129	920.19	835.86	1,131	541.21	468.54
Trading Asset Securities	63.88	55	-	-	-	-
Cash & Short-Term Investments	1,193	975.19	835.86	1,131	541.21	468.54
Cash Growth	-18.08%	16.67%	-26.08%	108.93%	15.51%	72.97%
Accounts Receivable	21,589	21,560	16,267	9,761	5,775	5,743
Other Receivables	-	-	3.04	0.01	0.07	-
Receivables	21,589	21,560	16,270	9,761	5,775	5,743
Inventory	10,219	8,246	6,575	3,195	2,614	2,359
Prepaid Expenses	99.65	51.74	24.34	28.39	38.8	46.45
Other Current Assets	2,080	1,694	1,769	1,823	1,543	1,061
Total Current Assets	35,181	32,527	25,474	15,937	10,511	9,678
Property, Plant & Equipment	3,342	3,076	2,672	2,184	2,156	1,468
Long-Term Investments	-	-	-	15.92	-	-
Other Intangible Assets	228.14	236.36	218.37	219.02	30.18	15.3
Long-Term Deferred Tax Assets	408.99	360.36	228.73	114.4	82	59.39
Total Assets	39,167	36,214	28,642	18,550	12,864	11,284
Accounts Payable	7,906	6,016	5,833	3,661	1,593	1,399
Accrued Expenses	328.03	196.1	147.65	123.05	63.21	43.42
Short-Term Debt	4,730	5,170	4,379	3,165	2,290	1,568
Current Portion of Long-Term Debt	20,349	19,563	14,402	8,673	6,339	5,910
Current Portion of Leases	256.68	242.69	230.65	117.94	90.41	71.2
Current Income Taxes Payable	326.52	256.99	203.05	79.91	26.73	59.55
Current Unearned Revenue	34.44	38.89	38.16	17.96	16.77	15.32
Other Current Liabilities	315.26	249.12	193.44	85.74	50.93	335.18
Total Current Liabilities	34,246	31,732	25,427	15,924	10,470	9,401
Long-Term Debt	1,243	891.23	47.46	556.02	852.18	204.83
Long-Term Leases	796.54	806.09	1,136	620.42	281.67	224.8
Other Long-Term Liabilities	-	-	-	-	0	-
Total Liabilities	36,285	33,430	26,610	17,101	11,604	9,831
Common Stock	252	252	252	252	279.04	240
Additional Paid-In Capital	237.41	237.41	237.41	237.41	277.5	277.5
Retained Earnings	2,564	2,466	1,713	1,131	901.63	948.62
Treasury Stock	-171.64	-171.64	-171.64	-171.64	-198.69	-14.4
Total Common Equity	2,882	2,784	2,031	1,449	1,259	1,452
Minority Interest	0	0	0	0	0.39	1.77
Shareholders' Equity	2,882	2,784	2,031	1,449	1,260	1,453
Total Liabilities & Equity	39,167	36,214	28,642	18,550	12,864	11,284
Total Debt	27,375	26,672	20,195	13,133	9,853	7,979
Net Cash (Debt)	-26,182	-25,697	-19,359	-12,002	-9,312	-7,510
Net Cash Per Share	-25.97	-25.49	-19.21	-11.91	-9.24	-5.77
Filing Date Shares Outstanding	1,008	1,008	1,008	1,008	1,008	1,226
Total Common Shares Outstanding	1,008	1,008	1,008	1,008	1,008	1,226
Working Capital	935.35	794.75	47.06	12.98	41.39	276.74
Book Value Per Share	2.86	2.76	2.02	1.44	1.25	1.18
Tangible Book Value	2,654	2,548	1,813	1,230	1,229	1,436
Tangible Book Value Per Share	2.63	2.53	1.80	1.22	1.22	1.17
Land	93.75	93.75	93.75	93.75	93.75	93.75
Buildings	888	887.51	847.39	807.75	724.3	692.7
Machinery	1,294	1,246	969.85	828.47	648.61	612.95
Construction In Progress	1,096	832.14	210.77	427.51	944.81	242.88